During the past decade, Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 6 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 4 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia" #1 collaborator was "Chugai" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia" are "Acute Myeloid Leukemia" (3 trials), "Breast Cancer" (2 trials), "Lymphoma, Non-Hodgkin" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials) and "Acute Lymphoblastic Leukemia" (1 trials). Many other conditions were trialed in "Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia" in a lesser frequency.

Most popular intervention types in "Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia" are "Drug" (24 trials), "Other" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (8 trials), "Cyclophosphamide" (5 trials), "Doxorubicin" (5 trials), "Placebo" (5 trials) and "Tocilizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia" are 29 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia". undefined are not yet recruiting, 8 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia, 5 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".